ArticleClinical rheumatology2025
Association of the ABCG2 Q141K variant with gout in Kinh Vietnamese: a cross-sectional study.
Article in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGout is a form of microcrystalline arthritis caused by chronic hyperuricemia, leading to monosodium urate crystal deposition. The ABCG2 gene, particularly the Q141K polymorphism, is a significant genetic factor influencing gout susceptibility and the therapeutic response to allopurinol. However, the association of Q141K with gout in the Vietnamese population remains undefined. This study investigates the relationship between the ABCG2 Q141K polymorphism and gout susceptibility among Kinh Vietnamese individuals. MATERIALS AND
methodsThis cross-sectional study includes 468 participants, comprising 234 gout patients and 234 controls. The basic clinical and paraclinical characteristics of all the participants were collected. Genomic DNA was extracted from peripheral blood samples and genotyped for the ABCG2 Q141K polymorphism using real-time PCR. The association of ABCG2 Q141K with gout and clinical characteristics was analyzed.
resultsThe ABCG2 Q141K polymorphism is significantly associated with gout in dominant, recessive, and additive genetic models. Specifically, the A allele was identified as a risk factor, observed in 46.8% of gout patients compared to 25% of healthy controls.
conclusionThe ABCG2 Q141K polymorphism significantly increases gout susceptibility among the Kinh Vietnamese population. The high frequency of the A allele in Vietnamese gout patients highlights the potential utility of genetic screening for appropriate preventive strategies. Key Points • The data regarding the contributions of genetic factors in gout of Vietnamese population remain insufficient. • This study showed that the ABCG2 Q141K polymorphism significantly increases gout susceptibility among the Kinh Vietnamese population.
Indexed as
Identifiers
40858881What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.